WO2025229605 - METHODS OF IDENTIFYING MARKERS OF ENTEROPATHIES
National phase entry is expected:
Publication Number
WO/2025/229605
Publication Date
06.11.2025
International Application No.
PCT/IB2025/054604
International Filing Date
01.05.2025
Title **
[English]
METHODS OF IDENTIFYING MARKERS OF ENTEROPATHIES
[French]
PROCÉDÉS D'IDENTIFICATION DE MARQUEURS D'ENTÉROPATHIES
Applicants **
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventors
SIEGELMAN, Jenifer
BUCKLER, Andrew J.
HACUNDA, James E.
LEFFLER, Daniel A.
SMITHSON, Glennda M.
Priority Data
63/641,565
02.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 10863 | |
| EPO | Filing, Examination, Granting | 199839 | |
| Japan | Filing, Examination, Granting | 5212 | |
| South Korea | Filing, Examination, Granting | 11827 | |
| USA | Filing, Examination, Granting | 46340 |
Total:
274,081
Contact Us
Abstract[English]
New and useful computer-implemented methods; methods of identifying markers associated with enteropathies; methods of determining the level of severity of an enteropathy; and determining a treatment for an enteropathy; are disclosed. In addition, the present disclosure provides methods of identifying a biological response to one or more treatments for an enteropathy, and whether a given treatment to an enteropathy results in a therapeutic or adverse effect, as determined in a spatiotemporal manner throughout the entirety of the small bowel, or a region of interest therein.[French]
L'invention concerne de nouveaux procédés mis en oeuvre par ordinateur utiles, des procédés d'identification de marqueurs associés à des entéropathies, des procédés de détermination du niveau de gravité d'une entéropathie, et la détermination d'un traitement pour une entéropathie. De plus, la présente invention concerne des procédés d'identification d'une réponse biologique à un ou plusieurs traitements pour une entéropathie, et si un traitement donné à une entéropathie conduit à un effet thérapeutique ou indésirable, tel que déterminé de manière spatio-temporelle dans toute la totalité du petit intestin, ou une région d'intérêt à l'intérieur de celui-ci.